Accrued Expenses

Current Liabilities

Thermo Fisher Scientific Accrued Expenses increased by 3.7% to $3.33B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.1%, from $3.20B to $3.33B. Over 5 years (FY 2020 to FY 2025), Accrued Expenses shows an upward trend with a 7.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2008
Last reportedQ4 2025

How to read this metric

Rising accruals often track with headcount growth or increased operational activity.

Detailed definition

Liabilities representing expenses that have been incurred but not yet paid or invoiced, such as employee wages, interest...

Peer comparison

Standard across all industries; usually scales linearly with the size of the workforce and operations.

Metric ID: accrued_expenses

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$1.86B$2.18B$2.95B$3.03B$2.96B$3.21B$3.35B$3.00B$2.98B$2.85B$3.25B$2.99B$3.02B$3.39B$3.20B$3.02B$3.20B$3.21B$3.33B
QoQ Change+16.9%+35.6%+2.8%-2.5%+8.4%+4.6%-10.7%-0.7%-4.3%+14.0%-8.0%+1.1%+12.4%-5.7%-5.5%+5.9%+0.3%+3.7%
YoY Change+58.9%+47.4%+13.7%-1.2%+0.6%-11.2%-3.2%-0.3%+1.5%+19.1%-1.4%+1.2%+6.0%-5.4%+4.1%
Range$1.86B$3.39B
CAGR+13.8%
Avg YoY Growth+8.6%
Median YoY Growth+1.2%
Current Streak3 quarters growth

Frequently Asked Questions

What is Thermo Fisher Scientific's accrued expenses?
Thermo Fisher Scientific (TMO) reported accrued expenses of $3.33B in Q4 2025.
How has Thermo Fisher Scientific's accrued expenses changed year-over-year?
Thermo Fisher Scientific's accrued expenses increased by 4.1% year-over-year, from $3.20B to $3.33B.
What is the long-term trend for Thermo Fisher Scientific's accrued expenses?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's accrued expenses has grown at a 7.5% compound annual growth rate (CAGR), from $2.31B to $3.33B.
What does accrued expenses mean?
Costs the company has run up but hasn't received a bill for yet.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.